Financial results and dividend declaration
AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
(“the Company")
Summarised Audited Results for the year ended 30 June 2020 and dividend declaration
Introduction to the AfroCentric Group
AfroCentric is a Level 1 black-owned JSE listed investment holding company, which owns and operates a
diverse range of healthcare related enterprises, which include, specialised medical scheme administration
and management, the supply of pharmaceuticals, including a range of healthcare products and services,
to both the public and private healthcare sectors. A principal objective of the group, is to ensure the delivery
of efficient health management services, the distribution of quality products, all at manageable and
affordable cost, for the benefit of scheme clients, scheme members and the group’s growing customer
base. AfroCentric has been able to successfully broaden its interests in the industry, by continuing to
pursue new opportunities, to expand and rationalise its presence in the healthcare sector.
The Board is pleased to present a summary of the Company’s results for the year ended 30 June 2020.
Salient Features
% Year ended Year ended
change 30 June 2020 30 June 2019
Total revenue 21.6 6 441.0 million 5 296.8 million
Operating profit 24.4 960.7 million 772.1 million
Operating profit (excluding lease reversals) 29.1 874.6 million 677.7 million
Healthcare Services Operating profit 13.2 620.8 million 548.4 million
Healthcare Retail Operating profit 96.4 253.8 million 129.2 million
Profit before tax 16.1 613.6 million 528.5 million
Basic earnings (rands) 12.5 303.6 million 269.9 million
Headline earnings (rands) 15.6 306.8 million 265.2 million
Basic earnings (cents per share) 9.9 52.87 48.12
Headline earnings (cents per share) 12.9 53.42 47.29
Weighted average number of ordinary shares 574.2 million 560.8 million
The information in this short form announcement has been extracted from the audited financial statements
for the year ended 30 June 2020. This announcement itself has not been audited.
Dividends
The Board has pleasure in announcing that in addition to the interim gross dividend per ordinary share of
17 cents, a final gross dividend of 17 cents per ordinary share has been declared for the year ended 30
June 2020. Dividends are subject to Dividends Withholding Tax. The payment date for the dividend is
Monday, 16 November 2020.
• Dividends have been declared out of profits available for distribution.
• Local Dividends Withholding Tax rate is 20%.
• The gross dividend amount is 17 cents per ordinary share.
• The net cash dividend amount is therefore 13.60000 cents per ordinary share.
• The Company has 574 241 248 ordinary shares in issue as at the declaration date.
• The Company’s income tax reference number is 9600/148/71/3.
The salient dates relating to the dividend are as follows:
Last day to trade cum dividend Tuesday, 10 November 2020
Shares commence trading ex-dividend Wednesday, 11 November 2020
Dividend record date Friday, 13 November 2020
Dividend payment date Monday, 16 November 2020
Share certificates for ordinary shares may not be dematerialised or rematerialized between Wednesday,
11 November 2020 and Friday, 13 November 2020, both days inclusive.
Full Announcement
This short-form announcement is the responsibility of the Directors of the Company and is a summary of the
information in the full announcement which is available for viewing on the following websites:
Company’s website: http://www.afrocentric.za.com/inv-reporting.php.
JSE website: https://senspdf.jse.co.za/documents/2020/jse/isse/act/act2020.pdf
The consolidated and company annual financial statements were audited by PricewaterhouseCoopers who
issued an unmodified audit opinion on these financial statements. Their audit opinion, together with the
accompanying financial statements, can be viewed on the Company’s website, which also provides more
details on the key audit matters on pages 15-16 of the annual financial statements.
Any investment decision by investors and/or shareholders should be based on consideration of the full
announcement, copies of which are also available for inspection at our offices on work-days during business
hours, at no charge:
On behalf of the Board
Dr ATM Mokgokong Mr A Banderker
Chairperson Group Chief Executive Officer
Johannesburg
14 September 2020
Sponsor: Sasfin Capital (a member of Sasfin Group)
Date: 14-09-2020 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.